Brief: CytoTools says treatment of diabetic foot with Dermapro not confirmed
27/11/2015 08:32
Nov 27 (Reuters) - CytoTools AG T5OG.DE :
* Says results of treatment of diabetic foot with Dermapro in Phase III clinical trail did
not confirm the results of previous studies
Source text for Eikon: ID:nEQbM2xvka
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)